Walgreen's other key metrics tick up as well.
Walgreen Company was a leading decliner within the retail industry, falling $1.14 (-1.9%) to $57.57 on average volume
The CVS Caremark acquisition of Coram is a good deal for investors.
Companies in distress can be great investment opportunities.
The oft-overlooked home infusion and alternative site infusion market represents a huge opportunity for CVS Caremark with its recent acquisition of leading infusion provider Coram Specialty Infusion Services.
Will Rite Aid’s stock continue to rise? How is the company doing compared to its peers including Walgreen and CVS Caremark?
A $2.1 billion investment from CVS catapults it into the leading provider of infusion drug services for patients; better positioning it against competitors Walgreen (WAG) and Rite-Aid (RAD).
Rite Aid's stock has broken out during this holiday week, leaving many investors to wonder how much higher can it trade and if it is still the best investment in the pharmacy space.
Prepaid cards have traditionally been lucrative for issuers, but Google has longer-term ambitions in mind. Find out whether Google's card is a good deal.
The holidays are a time for giving thanks, being around family, and stuffing our faces. It's also an unwelcome time of weight gain for many. Here are five companies that directly and indirectly could help people shed some pounds following the holiday season.
On Nov 27, we reiterated our long-term Neutral recommendation on CVS Caremark following healthy third-quarter 2013 results.
Retail clinics are becoming more popular as consumers look for low cost, just-in-time health care. With the Affordable Care Act expanding insurance coverage for millions, will retail clinics become profit centers for CVS, Walgreen, and Wal-Mart?
Real estate investment trust (REIT) Agree Realty Corp. announced the pricing of an equity offering of 1.65 million shares, which is projected to generate $49.2 million as gross proceeds.